Nuvectis Pharma, Inc. Profile Avatar - Palmy Investing

Nuvectis Pharma, Inc.

Nuvectis Pharma, Inc., a biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious unmet medical needs in oncology. It develops NXP800, a novel heat shock factor 1 pathway inhibitor for the treatment of var…

Biotechnology
US, Fort Lee [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Nuvectis Pharma, Inc. (NVCT) to it's peer group.

Peer Group
Loading...
End of NVCT's Analysis
CIK: 1875558 CUSIP: 67080T108 ISIN: US67080T1088 LEI: - UEI: -
Secondary Listings
NVCT has no secondary listings inside our databases.